CLNN 8-K 2026-11-04
Clene Inc. (CLNN) 8-K dated 2026-11-04 — accession 0001437749-26-034775.
Clene Inc. (CLNN) is a packaged foods company listed on US.
CLNN: CLENE REPORTS Third QUARTER 2026 FINANCIAL RESULTS
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CLNN revenue for 2025-12-31 was $200.0K. Net income was -$26.2M. Revenue was down 41.5% from 2024-12-31 to 2025-12-31. CLNN currently screens at market cap $34.1M.
Not investment advice. The CLNN SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects the proceeds from the offering to fund operations through mid-first quarter 2027. Subject to FDA acceptance of the NDA
Why it matters
- expects the proceeds from the offering to fund operations through mid-first quarter 2027. Subject to FDA acceptance of the NDA
- Clene’s submission of the NDA for CNM-Au8 is a pivotal achievement for the company and, more importantly, a meaningful step toward bringing new treatment opt…